Surgery can restore vision in patients with brain injuries

December 12, 2016 by Jim Dryden
During a retinal surgery, Rajendra Apte, MD, PhD, removes blood from a hemorrhage that had interfered with the patient's vision. Apte and his colleagues have found that such surgery can restore good vision in patients who have suffered traumatic brain injuries, even if the surgery has to be delayed for several weeks or months. Credit: Courtesy of the journal Ophthalmology

Surgery can restore vision in patients who have suffered hemorrhaging in the eye after a traumatic brain injury, even if the operation doesn't occur until several months after the injury, according to a small study from vision researchers at Washington University School of Medicine in St. Louis.

Reviewing cases at three medical centers in different parts of the world, researchers found that to remove the vitreous gel—which fills the space between the lens and the retina—netted 20/20 vision for most , even those who were legally blind before the operations.

The researchers, at Washington University School of Medicine in St. Louis, the Kresge Eye Institute at Wayne State University in Detroit and the L.V. Prasad Eye Institute in India, studied patients who developed hemorrhaging in the eye related to brain injuries suffered in . Prior to surgery, some patients could barely detect a hand waved in front of their faces. But a few months later, the majority had 20/20 vision.

The study is available online in the journal Ophthalmology.

"These patients often have other issues related to , and we can't work on the eye until a patient has stabilized," said principal investigator Rajendra S. Apte, MD, PhD, the Paul A. Cibis Distinguished Professor of Ophthalmology and Visual Sciences at Washington University School of Medicine. "It was important to learn how long we could wait to operate without having a negative effect on vision. In the majority of cases, it appears vision can be restored, even if the surgery is done several months after a ."

Accident victims and patients who experience brain aneurysms can develop bleeding in the back of the eye considered secondary to increased pressure in the skull due to hemorrhaging elsewhere inside of the head, a condition called Terson syndrome. Such hemorrhaging in the eye is serious because it causes vision loss and indicates that a patient's life may be in danger.

"When patients suffer from brain bleeds without any accompanying Terson syndrome in the eye, the risk for mortality is around 10 percent, but if there is hemorrhaging in the brain and the eye, mortality rates can be as high as 40-45 percent," said Apte, who treats patients at Barnes-Jewish Hospital.

The researchers analyzed results from 20 patients who had surgery for Terson syndrome, but because many develop hemorrhaging in both eyes, the scientists were able to examine the effects of surgery in a total of 28 eyes. The researchers divided patients into two groups: those who had the operation, called a vitrectomy, within three months of the hemorrhaging; and those who had surgery after the three-month mark.

"We are very cautious and conservative with these patients because many have other injuries that need to stabilize before we try to correct their vision and because sometimes a hemorrhage will dissipate on its own and won't require surgery," Apte said.

In a vitrectomy, the vitreous gel that sits between the eye's lens and retina, is removed and replaced with saline solution. Surgery in these patients helps restore vision by removing old blood that can prevent light signals from reaching photoreceptor cells in the retina following a hemorrhage.

The average vision in patients after their accidents but prior to their surgeries was 20/1290. Within one month of surgery, the average was 20/40. A few months later, almost all patients had 20/20 vision. There was no significant difference between those who had surgery right away and those who waited more than three months. The average visual acuity for all patients at the end of the study was 20/30, but that was partly due to three people in the study developing detached retinas that complicated their recoveries.

"In most situations where trauma causes bleeding in the brain that then leads to secondary bleeding in the eye, it seems likely that many patients will recover good after surgery, even if a few months pass before the operation," Apte said. "The only caveat would be that if the bleeding in the brain injures part of the visual cortex or other visual pathways, that may make it impossible for the brain to process signals from the retina. With that in mind, patients always should be counseled about that prior to surgery, whether that surgery is done shortly after the initial injury or several months later."

Explore further: 'Halo' effect common after lasik eye surgery

More information: Raja Narayanan et al. Visual Outcomes after Vitrectomy for Terson Syndrome Secondary to Traumatic Brain Injury, Ophthalmology (2016). DOI: 10.1016/j.ophtha.2016.09.009

Related Stories

'Halo' effect common after lasik eye surgery

December 3, 2016
(HealthDay)—Nine out of 10 Lasik laser eye surgery patients report satisfaction afterwards. But a sizable percentage experience new visual disturbances—like seeing halos around lights—up to six months after the procedure, ...

Substantial percentage of patients surveyed report new visual symptoms following LASIK surgery

November 23, 2016
In a study published online by JAMA Ophthalmology, Malvina Eydelman, M.D., of the U.S. Food and Drug Administration, Silver Spring, Md., and colleagues examined the frequency of patient-reported visual symptoms, dry eye symptoms, ...

Vitreomacular adhesion patients report improved vision with non-surgical treatment

June 17, 2015
In two ancillary studies of two multi-center international clinical trials led by the University of Southern California (USC) Eye Institute, the injectable drug ocriplasmin appears to improve vision among patients suffering ...

Bevacizumab, triamcinolone up outcome after cataract surgery

March 9, 2016
(HealthDay)—For patients undergoing cataract surgery, both bevacizumab and triamcinolone administered at the time of surgery correlate with improvements in visual acuity (VA), but only triamcinolone is associated with sustained ...

New technology improves vision for brain injury patients

September 28, 2016
The computer-delivered therapy is designed to improve speed and effectiveness of eye movements to better compensate for visual field loss.

Craniectomy after head injury reduces risk of death from brain swelling

September 8, 2016
Craniectomy – a surgical procedure in which part of the skull is removed to relieve brain swelling – significantly reduces the risk of death following traumatic brain injury, an international study led by the University ...

Recommended for you

Combination of type 2 diabetes and sleep apnoea indicates eyesight loss within four years

July 4, 2017
Research led by the University of Birmingham has discovered that patients who suffer from both Type 2 diabetes and obstructive sleep apnoea are at greater risk of developing a condition that leads to blindness within an average ...

Nearly 60% of pinkeye patients receive antibiotic eye drops, but they're seldom necessary

June 28, 2017
A new study suggests that most people with acute conjunctivitis, or pinkeye, are getting the wrong treatment.

Magnetic implants used to treat 'dancing eyes'

June 26, 2017
A research team has successfully used magnets implanted behind a person's eyes to treat nystagmus, a condition characterised by involuntary eye movements.

Drug shows promise against vision-robbing disease in seniors

June 21, 2017
An experimental drug is showing promise against an untreatable eye disease that blinds older adults—and intriguingly, it seems to work in patients who carry a particular gene flaw that fuels the damage to their vision.

Reproducing a retinal disease on a chip

June 15, 2017
Approximately 80% of all sensory input is received via the eyes, so suffering from chronic retinal diseases that lead to blindness causes a significant decrease in the quality of life (QOL). And because retinal diseases are ...

New gene therapy for vision loss proven safe in humans

May 16, 2017
In a small and preliminary clinical trial, Johns Hopkins researchers and their collaborators have shown that an experimental gene therapy that uses viruses to introduce a therapeutic gene into the eye is safe and that it ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.